Unlearn
Digital Twins for Clinical Trials
3 open rolesDigital Twins for Clinical TrialsSan Francisco, United States68 employees$135M raisedEst. 2017
Insight Partners
8VC
Altimeter Capital
DCVC
Radical Ventures
Mubadala Capital
About Unlearn
- Unlearn.AI is a biotech AI company that develops a digital twin service for clinical trials.
- It uses AI to create Digital Twins to populate Intelligent Control Arms, enabling smaller, more efficient clinical trials.
Unlearn is listed on Rocketlist with 3 active roles. The company is categorized as Digital Twins for Clinical Trials in BioTech. Unlearn is at Series C stage, with a B2B business model, headquartered in San Francisco, United States. Unlearn was founded in 2017 and has 68 employees. Unlearn has raised $135M. Active roles are refreshed daily from public hiring sources.